84 related articles for article (PubMed ID: 1105868)
1. [Treatment of Parkinson disease with Bromocriptine (CB 154 Sandoz) (author's transl)].
Jacobides GB; Audibert A
Ther Umsch; 1975 Jul; 32(7):469-71. PubMed ID: 1105868
[No Abstract] [Full Text] [Related]
2. [Treatment of parkinsonian syndromes by bromocriptin].
Gautier JC; Durand JP
Nouv Presse Med; 1977 Jan; 6(3):171-4. PubMed ID: 319421
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic usefulness of bromoergocriptine (CB-154 Sandoz) in patients with galactorrhea (author's transl)].
González Colindres JA; Canales ES; Levinson G; Zárate A; Sorta J
Rev Invest Clin; 1975; 27(2):135-8. PubMed ID: 1237173
[No Abstract] [Full Text] [Related]
4. Effects of lergotrile on schizophrenia & drug induced parkinsonism.
Small JG; Kellams JJ; Milstein V; Klapper M; Lemberger L
Commun Psychopharmacol; 1977; 1(5):461-7. PubMed ID: 23919
[No Abstract] [Full Text] [Related]
5. [Endocrine effects of bromocryptin in patients with Parkinsonism].
Barreca T; Gianrossi R; Gallamini A; Nizzo MC; Queirolo A
Boll Soc Ital Biol Sper; 1976 Oct; 52(19):1564-7. PubMed ID: 1037379
[No Abstract] [Full Text] [Related]
6. [Treatment of acromegaly with bromocriptine (CB 154)].
Schwinn G; Dirks H; Köbberling J
Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1896-9. PubMed ID: 801095
[No Abstract] [Full Text] [Related]
7. [Treatment of Parkinsonian syndrome using amantadine hydrochloride].
Schubert U; Fischer GJ; Glass J
Z Arztl Fortbild (Jena); 1975 May; 69(9):469-76. PubMed ID: 1106004
[No Abstract] [Full Text] [Related]
8. ["Use of bromocriptin (CB 154) in the treatment of puerperal and pathological lactation" (author's transl)].
del Pozo E
Schweiz Rundsch Med Prax; 1976 Feb; 65(7):181-5. PubMed ID: 1250831
[No Abstract] [Full Text] [Related]
9. Pergolide in late-stage Parkinson disease.
Lang AE; Quinn N; Brincat S; Marsden CD; Parkes JD
Ann Neurol; 1982 Sep; 12(3):243-7. PubMed ID: 6753730
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic effects of cyticholine (cytidine-diphospho-choline) in Parkinsonian syndrome].
Ruggieri S; Zamponi A; Casacchia M; Agnoli A
Clin Ter; 1976 Sep; 78(6):515-25. PubMed ID: 797506
[No Abstract] [Full Text] [Related]
11. [Letter: Efficacy of bromocriptine in 2 cases of levodopa-resistant parkinsonism].
Kissel P; Andre JM; Jacquier A
Nouv Presse Med; 1976 Jan; 5(4):210. PubMed ID: 1264671
[No Abstract] [Full Text] [Related]
12. [The "problem" of stopping loctation prevention and suppression with CB 154 (author's transl)].
Schneider D
Schweiz Rundsch Med Prax; 1976 Jan; 65(2):54-6. PubMed ID: 1257199
[No Abstract] [Full Text] [Related]
13. Subcutaneous infusion of apomorphine and lisuride in the treatment of parkinsonian on-off fluctuations.
Stibe C; Lees A; Stern G
Lancet; 1987 Apr; 1(8537):871. PubMed ID: 2882282
[No Abstract] [Full Text] [Related]
14. [Oral lisuride in Parkinson's disease].
Obeso JA; Luquin MR; Martínez Lage JM
Med Clin (Barc); 1985 Sep; 85(8):307-12. PubMed ID: 4068822
[No Abstract] [Full Text] [Related]
15. Stabilographic evaluation of dopaminergic and anticholinergic treatment of parkinsonism.
Cernacek J; Brezny I; Jagr J
Agressologie; 1973; 14(Spec No D):83-7. PubMed ID: 4608340
[No Abstract] [Full Text] [Related]
16. [The problem of side effects after a treatment with L-dopa in the Parkinson's syndrome: clinical and animal studies (author's transl)].
Sommer H; Fischer GJ; Quandt J
Folia Clin Int (Barc); 1974 Oct; 24(10):681-95. PubMed ID: 4279185
[No Abstract] [Full Text] [Related]
17. Lisuride treatment in Parkinson's disease: clinical and pharmacokinetic studies.
LeWitt PA; Burns RS; Calne DB
Adv Neurol; 1983; 37():131-40. PubMed ID: 6344586
[TBL] [Abstract][Full Text] [Related]
18. [Clinical efficacy of nicergoline in cerebrovascular diseases. Statistical study].
Guardamagna C; Negri S
Minerva Cardioangiol; 1972 Nov; 20(11):636-41. PubMed ID: 4566130
[No Abstract] [Full Text] [Related]
19. A 6-month trial of pergolide mesylate in the treatment of idiopathic Parkinson's disease.
Klawans HL; Tanner CM; Glatt S; Goetz CG
Adv Neurol; 1983; 37():75-83. PubMed ID: 6344592
[No Abstract] [Full Text] [Related]
20. Therapeutic results with a new ergoline derivate (8-alpha-amino-ergoline, CU 32-085) in parkinsonian patients.
Schneider E; Hubener K; Fischer PA
Adv Neurol; 1984; 40():527-9. PubMed ID: 6695631
[No Abstract] [Full Text] [Related]
[Next] [New Search]
